Skip to main content

Table 1 Tumour recurrence, metastasis and lymph-node invasion by post-operative stage and by Consensus Molecular Subtype

From: Molecular subtyping improves prognostication of Stage 2 colorectal cancer

 LR %Mets %Mets + LR %LM %LN %
TNM1011.311.39.40
TNM24.79.412.56.21.6
TNM36.731.432.42097.1
TNM44.510010081.886.4
P-value0.2407<  0.0001<  0.0001<  0.0001<  0.0001
CMS13.311.713.33.325
CMS24.126.226.921.437.9
CMS35.313.218.47.944.7
CMS4041.241.229.464.7
P-value*0.90610.02110.04790.00090.0171
  1. Tumour recurrence, metastasis and lymph-node invasion by Consensus Molecular Subtype (CMS) and by tumour-node-metastasis (TNM) stage given as percentages. P-value* is derived from analysis of classified tumours only and a P-value of < 0.05 is considered significant; LR Local recurrence, Mets, distant metastasis, diagnosed either at surgery or during the follow-up period; Mets + LR, local recurrence and distant metastasis combined; LM Liver metastasis, LN Lymph-node positive